Related Experiment Video
Updated: Nov 12, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society
Insights
Future research is needed to improve outcomes for central sleep apnea (CSA) in heart failure patients. Key priorities include understanding CSA pathophysiology, treatment impacts, and implementation strategies.
Area of Science:
- Sleep Medicine
- Cardiology
- Pulmonary Medicine
Background:
- Central sleep apnea (CSA) is prevalent in heart failure patients, associated with poor outcomes.
- Current progress in improving outcomes for these patients remains limited.
Purpose of the Study:
- To identify and prioritize key research areas for central sleep apnea (CSA) in heart failure.
- To guide future research efforts to advance patient care.
Main Methods:
- Convened an international, multidisciplinary expert workgroup.
- Conducted discussions at the American Thoracic Society 2019 International Conference.
- Authored a statement based on group consensus.
Main Results:
- Identified 11 specific research priorities for CSA in heart failure.
- Priorities span pathophysiology, individual variability, outcome assessment techniques, treatment efficacy (device and pharmacologic), and treatment implementation.
- Key areas include breathing control, CSA pathogenesis, and patient-centered outcomes.
Conclusions:
- Advancing care for heart failure patients with CSA requires progress in translational, epidemiological, and patient-centered outcome research.
- Targeted research is crucial given the rising prevalence of heart failure and its significant burden.
- Improving knowledge of CSA pathogenesis and treatment is a priority.
Abstract:
Background: Central sleep apnea (CSA) is common among patients with heart failure and has been strongly linked to adverse outcomes. However, progress toward improving outcomes for such patients has been limited. The purpose of this official statement from the American Thoracic Society is to identify key areas to prioritize for future research regarding CSA in heart failure.Methods: An international multidisciplinary group with expertise in sleep medicine, pulmonary medicine, heart failure, clinical research, and health outcomes was convened. The group met at the American Thoracic Society 2019 International Conference to determine research priority areas. A statement summarizing the findings of the group was subsequently authored using input from all members.Results: The workgroup identified 11 specific research priorities in several key areas: 1) control of breathing and pathophysiology leading to CSA, 2) variability across individuals and over time, 3) techniques to examine CSA pathogenesis and outcomes, 4) impact of device and pharmacological treatment, and 5) implementing CSA treatment for all individualsConclusions: Advancing care for patients with CSA in the context of heart failure will require progress in the arenas of translational (basic through clinical), epidemiological, and patient-centered outcome research. Given the increasing prevalence of heart failure and its associated substantial burden to individuals, society, and the healthcare system, targeted research to improve knowledge of CSA pathogenesis and treatment is a priority.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation II: ACLS Airway Management
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-IV
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

